| Title : Soluble epoxide hydrolase inhibitor trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea prevents hyperalgesia through regulating NLRC4 inflammasome-related pro-inflammatory and anti-inflammatory signaling pathways in the lipopolysaccharide-induced pain mouse model - Cagli_2021_Drug.Dev.Res__ |
| Author(s) : Cagli A , Senol SP , Temiz-Resitoglu M , Guden DS , Sari AN , Sahan-Firat S , Tunctan B |
| Ref : Drug Dev Res , : , 2021 |
| Abstract : Cagli_2021_Drug.Dev.Res__ |
| ESTHER : Cagli_2021_Drug.Dev.Res__ |
| PubMedSearch : Cagli_2021_Drug.Dev.Res__ |
| PubMedID: 33559150 |
| Title : Pharmacological inhibition of soluble epoxide hydrolase attenuates chronic experimental autoimmune encephalomyelitis by modulating inflammatory and anti-inflammatory pathways in an inflammasome-dependent and -independent manner - Biliktu_2020_Inflammopharmacology__ |
| Author(s) : Biliktu M , Senol SP , Temiz-Resitoglu M , Guden DS , Horat MF , Sahan-Firat S , Sevim S , Tunctan B |
| Ref : Inflammopharmacology , : , 2020 |
| Abstract : Biliktu_2020_Inflammopharmacology__ |
| ESTHER : Biliktu_2020_Inflammopharmacology__ |
| PubMedSearch : Biliktu_2020_Inflammopharmacology__ |
| PubMedID: 32128702 |